相关实验视频
Updated: Jul 25, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.7K
慢性慢性肺炎患者的血液和液中乙氨基的极化不同于喘患者的极化
Katarzyna Mycroft1, Magdalena Paplińska-Goryca1, Małgorzata Proboszcz1
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Cells
|June 28, 2023
概括
在慢性阻塞性肺病 (COPD) 和喘患者之间,唾液中的乙氨基酸表型不同. 这项研究揭示了COPD中明显的唾液乙素标记物,表明了独特的疾病特征.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 在喘和其他埃索诺菲尔性疾病中识别了埃索诺菲尔亚群.
- 在慢性阻塞性肺病 (COPD) 中对乙氨基基基亚群的数据有限.
- 了解COPD中乙氨基酸表型对于疾病的表征至关重要.
研究的目的:
- 为了比较COPD患者,喘患者和健康对照患者血液和诱导的中的乙氨基酸表型.
- 为了研究这些群体之间的氨酸标记表达和细胞因子概况的差异.
主要方法:
- 流细胞测量用于分析血液和唾液中的乙氨基类表型.
- 包括患有轻度至中度慢性肺炎 (n=15) 和喘 (n=14) 的患者,以及先前患有血红蛋白和对照组 (n=11).
- 在诱导的唾液中测量了细胞因子和化学因子水平 (IL-5,IL-13,CCL5,eotaxin-3).
主要成果:
- 在对照组,喘组和COPD组中,血液中氨基酸标记的表达是相似的.
- 与对照组和喘患者相比,COPD患者的液乙氨基酸表达CD193+和CD66b+的更高.
- 与COPD患者相比,喘患者表现出较高的CD11b+唾液乙氨基酸水平.
结论:
- 在COPD和喘患者之间,液中氨基酸标记表达特征显著不同.
- 与喘患者和健康人群相比,COPD患者在他们的呼吸道中可能具有独特的乙氨基类表型.
- 这些发现突出了欧诺菲尔参与COPD病变的潜在差异.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
240
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
240
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K

